Renal function during long-term therapy with rituximab in patients with systemic sclerosis
In systemic sclersis (SSc), different types of renal involvement occur. Their severity can range from asymptomatic deterioration of renal function to life-threatening damage, which is a complex therapeutic problem. Rituximab (RTM) has been used in the treatment of SSc and other autoimmune diseases w...
Saved in:
Main Authors: | M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2023-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1477 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of rituximab on heart involvement in systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2019-01-01) -
Challenges in diagnosis and treatment of scleroderma renal crisis (clinical case report)
by: E. M. Mishina, et al.
Published: (2025-06-01) -
Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab
by: L. P. Ananieva, et al.
Published: (2020-09-01) -
EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01) -
CURRENT VIEWS ON THE HETEROGENEITY OF RENAL INVOLVEMENTS IN PATIENTS WITH SYSTEMIC SCLEROSIS
by: A. V. Gordeev, et al.
Published: (2015-09-01)